BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8604003)

  • 21. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice.
    Broxmeyer HE; Williams DE; Cooper S; Hangoc G; Ralph P
    J Cell Biochem; 1988 Oct; 38(2):127-36. PubMed ID: 2464604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro.
    Gallicchio VS; Hughes NK; Hulette BC; DellaPuca R; Noblitt L
    Int J Cell Cloning; 1991 May; 9(3):220-32. PubMed ID: 2061622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
    Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
    Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ; van Eijk L; Schipper P; Löwenberg B
    Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Drize N; Chertkov J; Zander A
    Exp Hematol; 1995 Oct; 23(11):1180-6. PubMed ID: 7556528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.
    Bot FJ; van Eijk L; Schipper P; Backx B; Löwenberg B
    Leukemia; 1990 May; 4(5):325-8. PubMed ID: 1697008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment.
    Patchen ML; MacVittie TJ
    Acta Haematol; 1983; 70(5):281-8. PubMed ID: 6414220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
    Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
    Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 and granulocyte colony-stimulating factor synergistically increase peripheral blood progenitor cells in myelosuppressive mice.
    Suzuki H; Okano A; Ejima C; Konishi A; Akiyama Y; Ozawa K; Asano S
    Jpn J Cancer Res; 1996 Sep; 87(9):938-44. PubMed ID: 8878456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-administration of IL3 with G-CSF increases the CFU-S mobilization into peripheral blood.
    Ohi S; Sakamaki S; Matsunaga T; Kuga T; Hirayama Y; Kohgo Y; Niitsu Y
    Int J Hematol; 1995 Aug; 62(2):75-82. PubMed ID: 8590776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S; Pettit GR; McCrady C
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization.
    Morrison SJ; Wright DE; Weissman IL
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1908-13. PubMed ID: 9050878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.